SpectronRx
Anwer Rizvi has extensive leadership experience in the radiopharmaceutical industry, serving as President at SpectronRx since January 2019. Previously, Anwer held the same title at NCM USA from October 2011 to May 2015, and also at IBA Molecular NA from March 1995 to July 2010. Throughout this career, Anwer has focused on manufacturing and distribution within the sector.
This person is not in any teams
This person is not in any offices
SpectronRx
1 followers
SpectronRx is a CDMO that is FDA and EMA inspected. We are licensed to handle multiple Therapeutic and Diagnostic isotopes pharmaceutical grade including Pb-212, Lu-177, Ac-225 and I-131 for various clinical applications. Spectron operates under a quality program that has been inspected by the FDA with approved drugs FDG, NaF and Ammonia. Spectron provides labeling and contract manufacturing services as it relates to Lu-177, Ac-225, I-131, I-124, I-111, Zr-89, Copper-64 and Fluorine-18.